Exploring the Mechanism of “Fangyifang” in the Prevention of COVID-19 based on Network Pharmacology and Molecular Docking

Abstract

The novel coronavirus pneumonia (COVID-19) outbreak at the end of 2019 has continuously raged all around the world. Existing research has suggested that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) comprises single stranded positive strand RNA 1, which is easy to invade the respiratory and digestive systems of the body, thus causing several disease symptoms. More asymptomatic infections were identified with the deepening of research and the further optimization of detection technology 2. As of 2022, over 6 million people have died worldwide. SARS-COV-2 has exerted significant adverse effects on social and economic development and the lives of residents due to its high infectivity and pathogenicity.